Navigation Links
USP announces 11 new proposed monographs for dietary supplements
Date:11/15/2007

Rockville, Md., November 15, 2007 The U.S. Pharmacopeia (USP) is pleased to announce 11 new proposed monographs for dietary supplements for public notice and comment.

Six Turmeric-related monographs and three Soy Isoflavones monographs appeared in Pharmacopeial Forum (PF) 33(6), the issue corresponding to November/December 2007. These are Turmeric, Powdered Turmeric, Powdered Turmeric Extract, Curcuminoids, Curcuminoids Capsules, Curcuminoids Tablets, Soy Isoflavones Extract, Soy Isoflavones Capsules, and Soy Isoflavones Tablets. Two monographs for single ingredient amino acid formulations, arginine capsules and arginine tablets also appeared in PF 33(6). PF is the journal through which USP offers, for public review and comments, new and revised standards pertaining to the United States PharmacopeiaNational Formulary.

USP is pleased to release these new monographs in addition to the proposed monographs on Powdered Decaffeinated Green Tea Extract and Powdered Bilberry Extract published recently in PF 33(4) in July 2007, said Darrell Abernethy, M.D., Ph.D., chief science officer at USP. This is an important step towards advancing the quality of these dietary supplements, which are increasingly used by consumers. USP welcomes comments on the new monographs from all interested parties.

The proposed monographs contain specific and validated analytical methods that will ensure the identity of the articles and protect consumers and industry from low quality and adulterated products. For example, the proposed monograph on Powdered Bilberry Extract distinguishes the true extract from articles adulterated with azo dyes and other anthocyanin-containing botanicals. Green Tea, Turmeric and Soy Isoflavones monographs were also the subjects of a number of the 2006 National Institutes of Health research grants.

All 11 monographs address articles that are of great interest to the dietary supplements industry and to the scientific communi
'/>"/>

Contact: Sandra Kim
sek@usp.org
301-816-8241
US Pharmacopeia
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
2. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
3. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
4. HEI, Inc. Announces Sale of RFID Division Assets
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
8. Brooke Franchise Corporation Announces Selected July Results
9. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
11. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2008)..., ANN ARBOR, Mich.---The University of Michigan ...f Health to develop the world,s leading resource o...ng compounds that will ultimately take computer-ai...will house the data needed to improve computer pro...ial new drugs, said Heather Carlson, associate pro...
(Date:10/10/2008)... SUNNYVALE, Calif., Oct. 10 /PRNewswire-FirstCa...obal leader in the field of radiosurgery,today an...quarter fiscal,year 2009, ending September 27, 200... closes., A conference call to review the results...ill be hosted by Euan S. Thomson, Ph.D., president...
(Date:10/10/2008)... BALTIMORE, Oct. 10 /PRNewswire/ -- A nationall...treatment strategies for patients with breast,canc...reast Cancer,Strategies: From Biomarkers to Treatm...ness Month., It is challenging for practicing onc...s to stay up to date on the latest patient care,ad...
(Date:10/9/2008)... Let Them Hear Foundation hosts annual wine auc...amily venture, EAST PALO ALTO, Calif., Oct. 9 /PR...ls, California vintners, and local businesses and,...living in silence at the,fifth annual Crush the Si...Foundation at the Four Seasons Hotel, Silicon Vall...
Breaking Medicine News(10 mins):Health News:U-M to house leading drug database 2Health News:Accuray Incorporated to Report First Quarter Fiscal Year 2009 Financial Results 2Health News:Nationally Recognized Faculty Presents Latest Advances in Care of Patients with Breast Cancer 2Health News:Local Leaders Support Needy Individuals, Communities 2
...ked, President A.P.J. Abdul Kalam Thursday said th...ill women// who have no home. "While mental illne...themselves but also for their families, it becomes...ir families," Kalam said here at the beginning of ...
...ation of kidney diseases worldwide. According to s...are in the throes of kidney related ailments. Rep...o avoid kidney transplant is to detect the disease...s simply unaffordable for majority of the people i...
...e physicians are knowledgeable about women’s sleep...’ sleep problems. The survey issued by American Co...). It was found that most pulmonary/critical care ...erns of their female patients and are advising app...
...tt, urging the Commonwealth to convince the States...nd performance benchmarks for medical training in ... (AHCA) negotiations. The current AHCA expires i... the next agreement commence soon. AMA President...
Other Medicine News:Health News:Nearly 2,500 Mentally Ill Women in Delhi are Destitute: Abdul Kalam 2Health News:Doctors Not Drowsy When Treating Women’s Sleep Issue 2Health News:Doctors Not Drowsy When Treating Women’s Sleep Issue 3
(Date:10/8/2008)...(R) Element(TM) Platinum Chromium ...ewswire-FirstCall/ -- Boston Scientific,Corporatio...ted enrollment in,the PERSEUS trial, designed to e...ement(TM) paclitaxel-eluting coronary stent. The P...patients at 100 U.S. and,international centers sin...
(Date:10/7/2008)...etheus Laboratories Inc., a,specialty pharmaceutic...lopment of PROMETHEUS(R) IBS Diagnostic, the first...(IBS). The findings suggest measurable,differences...od samples,between IBS and non-IBS patients. The i... proprietary algorithm, led to the development of ...
(Date:10/7/2008)...e Osteoarthritis Research Society,International,s ...Newswire/ -- Ferring Pharmaceuticals Inc.,recently...thritis of the,Knee, showing that EUFLEXXA(R) (1% ...molecular weight form of intra-articular hyaluroni...ine (IA-saline) for the relief,of pain in knee ost...
(Date:10/7/2008)... taken once-daily significantly,improved the sympt... /- Shire plc (LSE: SHP,Na...al company, today,announced that a study published... Psychiatry found once-daily VYVANSE significantly... (ADHD) symptoms in adults within,the first week o...
Breaking Medicine Technology:Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 2Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 3Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 4Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting 2Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting 3Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 2Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 3Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 4Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 2Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 3Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 4Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 5Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 6About one quarter of women with HIV want to become pregnant 12652 1About one quarter of women with HIV want to become pregnant 12652 2About one quarter of women with HIV want to become pregnant 12652 3About one quarter of women with HIV want to become pregnant 12652 4Danaher to Present at Citigroup Global Industrial Manufacturing Conference 12649 1Three Year Analysis of Treatment Efficacy Cosmesis and Toxicity Support use of the Hologic Mammosite Radiation Therapy System 1428 1Three Year Analysis of Treatment Efficacy Cosmesis and Toxicity Support use of the Hologic Mammosite Radiation Therapy System 1428 2Three Year Analysis of Treatment Efficacy Cosmesis and Toxicity Support use of the Hologic Mammosite Radiation Therapy System 1428 3Three Year Analysis of Treatment Efficacy Cosmesis and Toxicity Support use of the Hologic Mammosite Radiation Therapy System 1428 4Antibiotic Use in Dementia Patients Questioned 12644 1Antibiotic Use in Dementia Patients Questioned 12644 2Antibiotic Use in Dementia Patients Questioned 12644 3
...essed protein,protects human pancreatic cancer cel...g one of the body,s natural defenses against,out-o...ty of Texas,M. D. Anderson Cancer Center report in...he protein tissue transglutaminase, known by the a...archers at M. D. Anderson and,elsewhere to be over...
...Clinical studies have,shown (1) similar rates of n...uenza patients being treated with Tamiflu compared...za. Furthermore,recent data derived from US healt...101,000 influenza patients treated with Tamiflu,an...lu have shown,that the Tamiflu treated patients sh...
Other Medicine Technology:Protein Found to Shield Pancreatic Cancer Cells from,Self-Destruction 2Protein Found to Shield Pancreatic Cancer Cells from,Self-Destruction 3New Data from the US and Japan Support: No Established Causal Link,Between Neuropsychiatric Symptoms and Treatment with Tamiflu US,Databases Indicate Psychiatric Symptoms Lower in Influenza Patients,Taking Tamiflu Versus Those Not Taking Tamiflu 2New Data from the US and Japan Support: No Established Causal Link,Between Neuropsychiatric Symptoms and Treatment with Tamiflu US,Databases Indicate Psychiatric Symptoms Lower in Influenza Patients,Taking Tamiflu Versus Those Not Taking Tamiflu 3New Data from the US and Japan Support: No Established Causal Link,Between Neuropsychiatric Symptoms and Treatment with Tamiflu US,Databases Indicate Psychiatric Symptoms Lower in Influenza Patients,Taking Tamiflu Versus Those Not Taking Tamiflu 4
Duckbill. 3.5 mm tip. Light curve.
Duckbill type, sharp. 3 mm x 8 mm curved blade. Octagonal handle.
4 mm x 9 mm tip.
2 mm curved tip. Round handle. Designated most popular model or size.
Medicine Products: